aminoimidazole carboxamide has been researched along with am 251 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HS; Kwon, J; Lee, ES; Lee, YM; Park, SH; Uhm, KO | 1 |
Ferreirós, N; Geisslinger, G; King-Himmelreich, TS; Möser, CV; Niederberger, E; Russe, OQ; Schmetzer, J; Schreiber, Y; Wolters, MC | 1 |
2 other study(ies) available for aminoimidazole carboxamide and am 251
Article | Year |
---|---|
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway.
Topics: Activating Transcription Factor 3; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Cannabinoids; Cell Line, Tumor; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; Multienzyme Complexes; Phosphorylation; Piperidines; Protein Serine-Threonine Kinases; Pyrazoles; Ribonucleotides; Signal Transduction | 2008 |
AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids.
Topics: Amidohydrolases; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Arachidonic Acids; Cells, Cultured; Endocannabinoids; Female; Male; Mice; Mice, Knockout; Neurons; Nociception; Pain Measurement; Physical Conditioning, Animal; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Ribonucleotides | 2017 |